REFRACTORY BRAIN NEOPLASM
Clinical trials for REFRACTORY BRAIN NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY BRAIN NEOPLASM trials appear
Sign up with your email to follow new studies for REFRACTORY BRAIN NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough cancers: scientists test Triple-Threat drug cocktail in kids
Disease control OngoingThis early-stage trial is testing a new combination of three drugs—dasatinib, temsirolimus, and cyclophosphamide—to treat advanced solid tumors that have come back or stopped responding to other treatments. The main goal is to find the safest dose and understand the side effects.…
Matched conditions: REFRACTORY BRAIN NEOPLASM
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope for kids with aggressive brain cancers: early trial tests immune therapy
Disease control OngoingThis early-stage trial is testing the safety and early effectiveness of a drug called pembrolizumab in children with aggressive brain tumors that have come back or stopped responding to standard treatments. The drug is an immunotherapy, which aims to help the body's own immune sy…
Matched conditions: REFRACTORY BRAIN NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC